DK3157510T3 - Antimikrobielle sammensætninger med brusemidler - Google Patents
Antimikrobielle sammensætninger med brusemidler Download PDFInfo
- Publication number
- DK3157510T3 DK3157510T3 DK15810507.2T DK15810507T DK3157510T3 DK 3157510 T3 DK3157510 T3 DK 3157510T3 DK 15810507 T DK15810507 T DK 15810507T DK 3157510 T3 DK3157510 T3 DK 3157510T3
- Authority
- DK
- Denmark
- Prior art keywords
- antimicrobial compositions
- effervescent agents
- effervescent
- agents
- antimicrobial
- Prior art date
Links
- 230000000845 anti-microbial effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462014786P | 2014-06-20 | 2014-06-20 | |
PCT/US2015/036605 WO2015196027A1 (en) | 2014-06-20 | 2015-06-19 | Antimicrobial compositions with effervescent agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3157510T3 true DK3157510T3 (da) | 2019-07-01 |
Family
ID=54868661
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15810507.2T DK3157510T3 (da) | 2014-06-20 | 2015-06-19 | Antimikrobielle sammensætninger med brusemidler |
DK19165084.5T DK3581180T3 (da) | 2014-06-20 | 2015-06-19 | Antimikrobielle sammensætninger med brusemidler |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK19165084.5T DK3581180T3 (da) | 2014-06-20 | 2015-06-19 | Antimikrobielle sammensætninger med brusemidler |
Country Status (32)
Country | Link |
---|---|
US (2) | US20150366857A1 (da) |
EP (3) | EP3919057A1 (da) |
JP (2) | JP6995479B2 (da) |
CN (2) | CN106572982B9 (da) |
AR (1) | AR100920A1 (da) |
AU (3) | AU2015276954B2 (da) |
BR (1) | BR112016029761B1 (da) |
CA (1) | CA2952950C (da) |
CL (2) | CL2016003273A1 (da) |
CR (2) | CR20200565A (da) |
CY (2) | CY1121995T1 (da) |
DK (2) | DK3157510T3 (da) |
EA (1) | EA034152B1 (da) |
EC (1) | ECSP16095540A (da) |
ES (2) | ES2732865T3 (da) |
HR (2) | HRP20211685T1 (da) |
HU (2) | HUE044764T2 (da) |
IL (1) | IL249622A0 (da) |
LT (2) | LT3157510T (da) |
MX (2) | MX368940B (da) |
PE (2) | PE20210927A1 (da) |
PH (2) | PH12016502548B1 (da) |
PL (2) | PL3157510T3 (da) |
PT (2) | PT3157510T (da) |
RS (2) | RS62538B1 (da) |
SI (2) | SI3157510T1 (da) |
SM (2) | SMT202100618T1 (da) |
SV (1) | SV2016005349A (da) |
TR (1) | TR201909417T4 (da) |
TW (2) | TWI732337B (da) |
UY (1) | UY36184A (da) |
WO (1) | WO2015196027A1 (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022240897A1 (en) * | 2021-05-10 | 2022-11-17 | Sepelo Therapeutics, Llc | Pharmaceutical composition comprising delafloxacin for administration into the lung |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5194617A (en) * | 1988-12-17 | 1993-03-16 | Meiji Seika Kaisha, Ltd. | 2,3-disubstituted-4-hydroxyquinoline derivatives |
US5223264A (en) * | 1989-10-02 | 1993-06-29 | Cima Labs, Inc. | Pediatric effervescent dosage form |
GB9402203D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Pharmaceutical formulation |
WO1997011068A1 (fr) | 1995-09-22 | 1997-03-27 | Wakunaga Pharmaceutical Co., Ltd. | Nouveaux derives de l'acide pyridone-carboxylique ou leurs sels et agent antibacterien les contenant comme ingredient actif |
US6350470B1 (en) * | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
DE19814256A1 (de) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Feste, schnellzerfallende Cetirizin-Formulierungen |
UA73287C2 (en) | 1998-09-14 | 2005-07-15 | Ranbaxy Lab Ltd | Ciprofloxacin formulation with delayed release |
US6187317B1 (en) * | 1999-07-14 | 2001-02-13 | Judith Taylor | Natural anti-diarrheal composition and method |
US6414036B1 (en) * | 1999-09-01 | 2002-07-02 | Van Beek Global/Ninkov Llc | Composition for treatment of infections of humans and animals |
JP2005097116A (ja) | 1999-11-11 | 2005-04-14 | Wakunaga Pharmaceut Co Ltd | キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法 |
WO2003101431A1 (en) * | 2002-06-04 | 2003-12-11 | J.B. Chemicals & Pharmaceuticals Ltd. | Pharmaceutical composition for controlled drug delivery system |
MX2007001134A (es) | 2004-07-30 | 2007-04-17 | Abbott Lab | Preparacion de antibacterianos de acido piridonacarboxilico. |
DK3056492T3 (da) * | 2004-10-08 | 2021-12-13 | Abbvie Inc | Megluminsalt og krystallinke former deraf af et lægemiddel (delafloxacin) |
BRPI0517891A (pt) * | 2004-11-24 | 2008-10-21 | Medpointe Healthcare Inc | composições compreendendo azelastina e métodos de uso das mesmas |
RS52354B (en) | 2005-04-11 | 2012-12-31 | Abbott Laboratories | PHARMACEUTICAL MIXTURES WHICH HAVE ADVANCED DISSOLUTION PROFILES FOR Slightly Soluble Medicines |
DE602005007205D1 (de) | 2005-07-19 | 2008-07-10 | Ethypharm Sa | Gastroretentive Zusammensetzungen und Verfahren zur Herstellung |
US7611739B2 (en) | 2006-01-06 | 2009-11-03 | Amerilab Technologies, Inc. | Method of using guava extract and composition including guava extract |
US7736485B2 (en) * | 2006-08-11 | 2010-06-15 | Aqua Resources Corporation | Nanoplatelet magnesium hydroxides and methods of preparing same |
CN1943561A (zh) * | 2006-08-23 | 2007-04-11 | 北京阜康仁生物制药科技有限公司 | 普卢利沙星口腔崩解片及其制备方法 |
NZ578204A (en) | 2006-12-22 | 2012-05-25 | Ironwood Pharmaceuticals Inc | Compositions comprising bile acid sequestrants for treating esophageal disorders |
AU2008258596B2 (en) * | 2007-06-04 | 2013-02-14 | Egalet Ltd | Controlled release pharmaceutical compositions for prolonged effect |
EA025637B1 (ru) * | 2008-11-15 | 2017-01-30 | Мелинта Терапьютикс, Инк. | Противомикробные композиции |
WO2010096551A2 (en) * | 2009-02-18 | 2010-08-26 | Rib-X Pharmaceuticals, Inc. | Antimicrobial compositions |
GB201020076D0 (en) * | 2010-11-26 | 2011-01-12 | Liverpool School Tropical Medicine | Antimalarial compounds |
EP3581574A1 (en) * | 2011-01-10 | 2019-12-18 | Infinity Pharmaceuticals, Inc. | A composition for oral administration for use in the treatment of cancer, an inflammatory disease or an auto-immune disease |
KR101900249B1 (ko) * | 2011-01-14 | 2018-11-02 | 스페로 트리넴, 인코포레이티드 | 자이라제 억제제 (r)1에틸3[6플루오로5[2(1하이드록시1메틸에틸)피리미딘5일]7(테트라하이드로푸란2일)1h벤즈이미다졸2일]우레아의 고체 형태 |
JP2013034468A (ja) * | 2011-08-10 | 2013-02-21 | Nisshin Sugar Mfg Co Ltd | 発泡成型甘味料 |
US20140328884A1 (en) * | 2011-12-16 | 2014-11-06 | Celanese Eva Performance Polymers, Inc. | Controlled release vehicles having desired void volume architectures |
CN102697751A (zh) * | 2012-05-30 | 2012-10-03 | 河南牧翔动物药业有限公司 | 一种畜禽专用恩诺沙星泡腾分散片及其制备方法 |
-
2015
- 2015-06-18 TW TW108140999A patent/TWI732337B/zh active
- 2015-06-18 TW TW104119676A patent/TWI705814B/zh active
- 2015-06-19 PH PH1/2016/502548A patent/PH12016502548B1/en unknown
- 2015-06-19 SM SM20210618T patent/SMT202100618T1/it unknown
- 2015-06-19 WO PCT/US2015/036605 patent/WO2015196027A1/en active Application Filing
- 2015-06-19 DK DK15810507.2T patent/DK3157510T3/da active
- 2015-06-19 PL PL15810507T patent/PL3157510T3/pl unknown
- 2015-06-19 CN CN201580044451.8A patent/CN106572982B9/zh active Active
- 2015-06-19 CA CA2952950A patent/CA2952950C/en active Active
- 2015-06-19 HU HUE15810507 patent/HUE044764T2/hu unknown
- 2015-06-19 ES ES15810507T patent/ES2732865T3/es active Active
- 2015-06-19 HR HRP20211685TT patent/HRP20211685T1/hr unknown
- 2015-06-19 PH PH1/2022/550979A patent/PH12022550979A1/en unknown
- 2015-06-19 LT LTEP15810507.2T patent/LT3157510T/lt unknown
- 2015-06-19 HU HUE19165084A patent/HUE056298T2/hu unknown
- 2015-06-19 ES ES19165084T patent/ES2897576T3/es active Active
- 2015-06-19 BR BR112016029761-0A patent/BR112016029761B1/pt active IP Right Grant
- 2015-06-19 EA EA201692532A patent/EA034152B1/ru unknown
- 2015-06-19 RS RS20211307A patent/RS62538B1/sr unknown
- 2015-06-19 US US14/744,432 patent/US20150366857A1/en not_active Abandoned
- 2015-06-19 PE PE2021000031A patent/PE20210927A1/es unknown
- 2015-06-19 SI SI201530783T patent/SI3157510T1/sl unknown
- 2015-06-19 CR CR20200565A patent/CR20200565A/es unknown
- 2015-06-19 AR ARP150101976A patent/AR100920A1/es unknown
- 2015-06-19 CN CN202210565182.1A patent/CN114831955B/zh active Active
- 2015-06-19 RS RS20190773A patent/RS59064B1/sr unknown
- 2015-06-19 EP EP21188004.2A patent/EP3919057A1/en active Pending
- 2015-06-19 EP EP19165084.5A patent/EP3581180B1/en active Active
- 2015-06-19 EP EP15810507.2A patent/EP3157510B1/en active Active
- 2015-06-19 SI SI201531733T patent/SI3581180T1/sl unknown
- 2015-06-19 PT PT15810507T patent/PT3157510T/pt unknown
- 2015-06-19 PT PT191650845T patent/PT3581180T/pt unknown
- 2015-06-19 PL PL19165084T patent/PL3581180T3/pl unknown
- 2015-06-19 PE PE2016002748A patent/PE20170304A1/es unknown
- 2015-06-19 DK DK19165084.5T patent/DK3581180T3/da active
- 2015-06-19 JP JP2016574040A patent/JP6995479B2/ja active Active
- 2015-06-19 SM SM20190348T patent/SMT201900348T1/it unknown
- 2015-06-19 TR TR2019/09417T patent/TR201909417T4/tr unknown
- 2015-06-19 CR CR20160592A patent/CR20160592A/es unknown
- 2015-06-19 MX MX2016017350A patent/MX368940B/es active IP Right Grant
- 2015-06-19 AU AU2015276954A patent/AU2015276954B2/en active Active
- 2015-06-19 LT LTEP19165084.5T patent/LT3581180T/lt unknown
- 2015-06-22 UY UY0001036184A patent/UY36184A/es not_active Application Discontinuation
-
2016
- 2016-12-18 IL IL249622A patent/IL249622A0/en unknown
- 2016-12-20 CL CL2016003273A patent/CL2016003273A1/es unknown
- 2016-12-20 MX MX2019012608A patent/MX2019012608A/es unknown
- 2016-12-20 SV SV2016005349A patent/SV2016005349A/es unknown
- 2016-12-20 EC ECIEPI201695540A patent/ECSP16095540A/es unknown
-
2019
- 2019-06-21 HR HRP20191133TT patent/HRP20191133T1/hr unknown
- 2019-06-26 CY CY20191100664T patent/CY1121995T1/el unknown
-
2020
- 2020-01-28 US US16/774,709 patent/US20200237744A1/en not_active Abandoned
- 2020-07-15 JP JP2020121083A patent/JP7149991B2/ja active Active
- 2020-10-17 AU AU2020256457A patent/AU2020256457B2/en active Active
- 2020-12-03 CL CL2020003153A patent/CL2020003153A1/es unknown
-
2021
- 2021-11-04 CY CY20211100955T patent/CY1125395T1/el unknown
- 2021-12-14 AU AU2021286284A patent/AU2021286284B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1251922A1 (zh) | 抗微生物組合物及其用途 | |
PL3236978T3 (pl) | Kompozycja przeciwdrobnoustrojowa | |
DK3040326T3 (da) | Haloolefin-baseret sammensætning | |
DK3542812T3 (da) | Glycopeptidsammensætninger | |
BR112016023341A2 (pt) | composição desinfetante de ação rápida | |
BR112017001922A2 (pt) | composições fungicidas | |
EP3415008A4 (en) | GERMIC COMPOSITION | |
FR3024363B1 (fr) | Composition thermogelifiable | |
PT3261437T (pt) | Compostos e composições fungicidas | |
EP3443078A4 (en) | ANTIMICROBIAL COMPOSITIONS | |
CL2017000639A1 (es) | Composición | |
DK3451829T3 (da) | Antimikrobielle sammensætninger | |
BR112016018442A2 (pt) | agentes antibacterianos | |
FR3020948B1 (fr) | Composition antimicrobienne | |
EP3236746C0 (en) | COMPOSITION | |
DK3200827T3 (da) | Sammensætninger | |
DK3217964T3 (da) | Sammensætning | |
FR3025106B1 (fr) | Composition antimicrobienne | |
FR3019552B1 (fr) | Composition filmogene | |
EP3405218A4 (en) | DISINFECTING COMPOSITION | |
DK3174396T3 (da) | Synergistisk antimikrobiel sammensætning | |
DK3157510T3 (da) | Antimikrobielle sammensætninger med brusemidler | |
MA40840A (fr) | Composition herbicide | |
EP3509419C0 (en) | ANTIMICROBIAL COMPOSITION | |
UA28385S (uk) | Пластир бактерицидний |